Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $2.8 million.

  • Veracyte's Gains from Investment Securities rose 2908.26% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.9 million, marking a year-over-year increase of 11226.01%. This contributed to the annual value of $10.6 million for FY2024, which is 5708.35% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Gains from Investment Securities is $2.8 million, which was up 2908.26% from $2.4 million recorded in Q2 2025.
  • Veracyte's 5-year Gains from Investment Securities high stood at $9.5 million for Q1 2025, and its period low was $418000.0 during Q2 2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was $1.4 million (2022), whereas its average is $2.3 million.
  • As far as peak fluctuations go, Veracyte's Gains from Investment Securities crashed by 8717.21% in 2021, and later surged by 21602.07% in 2023.
  • Over the past 5 years, Veracyte's Gains from Investment Securities (Quarter) stood at $722000.0 in 2021, then dropped by 26.87% to $528000.0 in 2022, then soared by 113.45% to $1.1 million in 2023, then surged by 190.51% to $3.3 million in 2024, then decreased by 14.05% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q3 2025, $2.4 million for Q2 2025, and $9.5 million during Q1 2025.